6D53

Trans form of HemolysinII c-terminal domain


SOLUTION NMR
NMR Experiment
ExperimentTypeSample ContentsSolventIonic StrengthpHPressureTemperature (K)Spectrometer
13D HNCACB1.0 mM [U-99% 13C; U-99% 15N] HlyIIC, 20 mM sodium phosphate, 1 mM EDTA, 0.05 % w/v sodium azide, 1 mM AEBSF protease inhibitor90% H2O/10% D2O0 M6.01 atm310Varian INOVA 800
23D HN(CO)CA1.0 mM [U-99% 13C; U-99% 15N] HlyIIC, 20 mM sodium phosphate, 1 mM EDTA, 0.05 % w/v sodium azide, 1 mM AEBSF protease inhibitor90% H2O/10% D2O0 M6.01 atm310Varian INOVA 800
33D HNCO1.0 mM [U-99% 13C; U-99% 15N] HlyIIC, 20 mM sodium phosphate, 1 mM EDTA, 0.05 % w/v sodium azide, 1 mM AEBSF protease inhibitor90% H2O/10% D2O0 M6.01 atm310Varian INOVA 800
43D HN(CA)CO1.0 mM [U-99% 13C; U-99% 15N] HlyIIC, 20 mM sodium phosphate, 1 mM EDTA, 0.05 % w/v sodium azide, 1 mM AEBSF protease inhibitor90% H2O/10% D2O0 M6.01 atm310Varian INOVA 800
52D 1H-15N HSQC1.0 mM [U-99% 13C; U-99% 15N] HlyIIC, 20 mM sodium phosphate, 1 mM EDTA, 0.05 % w/v sodium azide, 1 mM AEBSF protease inhibitor90% H2O/10% D2O0 M6.01 atm310Varian INOVA 800
63D HNHA1.0 mM [U-99% 15N] HlyIIC, 20 mM sodium phosphate, 1 mM EDTA, 1 mM AEBSF protease inhibitor, 0.05 % w/v sodium azide90% H2O/10% D2O0 M6.01 atm310Varian INOVA 600
73D HNHB1.0 mM [U-99% 15N] HlyIIC, 20 mM sodium phosphate, 1 mM EDTA, 1 mM AEBSF protease inhibitor, 0.05 % w/v sodium azide90% H2O/10% D2O0 M6.01 atm310Varian INOVA 600
82D DQF-COSY1.0 mM [U-99% 15N] HlyIIC, 20 mM sodium phosphate, 1.0 mM EDTA, 1.0 mM AEBSF protease inhibitor, 0.05 % w/v sodium azide100% D2O0 M6.01 atm310Varian INOVA 600
92D 1H-1H NOESY1.0 mM [U-99% 15N] HlyIIC, 20 mM sodium phosphate, 1.0 mM EDTA, 1.0 mM AEBSF protease inhibitor, 0.05 % w/v sodium azide100% D2O0 M6.01 atm310Varian INOVA 600
102D 1H-13C HSQC1.0 mM [U-99% 13C; U-99% 15N] HlyIIC, 20 mM sodium phosphate, 1 mM EDTA, 0.05 % w/v sodium azide, 1 mM AEBSF protease inhibitor90% H2O/10% D2O0 M6.01 atm310Varian INOVA 800
112D 1H-1H TOCSY1.0 mM [U-99% 13C; U-99% 15N] HlyIIC, 20 mM sodium phosphate, 1 mM EDTA, 0.05 % w/v sodium azide, 1 mM AEBSF protease inhibitor90% H2O/10% D2O0 M6.01 atm310Varian INOVA 800
123D HCCH-TOCSY1.0 mM [U-99% 13C; U-99% 15N] HlyIIC, 20 mM sodium phosphate, 1 mM EDTA, 0.05 % w/v sodium azide, 1 mM AEBSF protease inhibitor90% H2O/10% D2O0 M6.01 atm310Varian INOVA 800
133D CCH-TOCSY1.0 mM [U-99% 13C; U-99% 15N] HlyIIC, 20 mM sodium phosphate, 1 mM EDTA, 0.05 % w/v sodium azide, 1 mM AEBSF protease inhibitor90% H2O/10% D2O0 M6.01 atm310Varian INOVA 800
143D 1H-15N TOCSY1.0 mM [U-99% 15N] HlyIIC, 20 mM sodium phosphate, 1 mM EDTA, 1 mM AEBSF protease inhibitor, 0.05 % w/v sodium azide90% H2O/10% D2O0 M6.01 atm310Varian INOVA 600
153D 1H-13C NOESY aliphatic1.0 mM [U-99% 13C; U-99% 15N] HlyIIC, 20 mM sodium phosphate, 1 mM EDTA, 0.05 % w/v sodium azide, 1 mM AEBSF protease inhibitor90% H2O/10% D2O0 M6.01 atm310Varian INOVA 800
163D 1H-15N NOESY1.0 mM [U-99% 15N] HlyIIC, 20 mM sodium phosphate, 1 mM EDTA, 1 mM AEBSF protease inhibitor, 0.05 % w/v sodium azide90% H2O/10% D2O0 M6.01 atm310Varian INOVA 600
NMR Spectrometer Information
SpectrometerManufacturerModelField Strength
1VarianINOVA800
2VarianINOVA600
NMR Refinement
MethodDetailsSoftware
molecular dynamicsARIA
NMR Ensemble Information
Conformer Selection Criteriastructures with the least restraint violations
Conformers Calculated Total Number100
Conformers Submitted Total Number25
Representative Model1 (closest to the average)
Computation: NMR Software
#ClassificationVersionSoftware NameAuthor
1chemical shift assignmentCcpNMR2.4CCPN
2processingFelixAccelrys Software Inc.
3data analysisCcpNMR2.4CCPN
4peak pickingCcpNMRCCPN
5geometry optimizationTALOS-NCornilescu, Delaglio and Bax
6structure calculationXPLOR NIHSchwieters, Kuszewski, Tjandra and Clore
7refinementARIA2.3Linge, O'Donoghue and Nilges